Shree Pacetronix Ltd

Shree Pacetronix Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Shree Pacetronix Ltd

₹ 138 -0.86%
12 Jun - close price
shreepacetronix.com; www.pacetronix.com BSE: 527005
About

Incorporated in 1988, Shree Pacetronix Ltd
is in the business of trading of Pacemakers.[1]

Key Points

Business Overview:[1]
SPL is in the business of delivering MRI safe life saving critical medical devices that regulate heart rhythms and improve the quality of life for patients suffering from cardiac conditions
such as arrhythmias and heart failure.

Website BSE
  • Market Cap ₹ 51.7 Cr.
  • Current Price ₹ 138
  • High / Low ₹ 283 / 66.1
  • Stock P/E 16.5
  • Book Value ₹ 48.3
  • Dividend Yield 0.00 %
  • ROCE 23.3 %
  • ROE 19.7 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is expected to give good quarter

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 31.7%
  • Company has high debtors of 179 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
7.52 5.86 5.23 4.30 6.65 4.85 4.04 3.63 4.28 5.34 6.59 4.33 5.37
4.55 4.48 4.08 3.45 4.23 4.07 3.63 3.49 3.30 4.18 4.58 3.90 3.74
Operating Profit 2.97 1.38 1.15 0.85 2.42 0.78 0.41 0.14 0.98 1.16 2.01 0.43 1.63
OPM % 39.49% 23.55% 21.99% 19.77% 36.39% 16.08% 10.15% 3.86% 22.90% 21.72% 30.50% 9.93% 30.35%
0.04 0.04 0.02 0.03 0.05 0.05 0.02 0.02 0.03 0.02 0.03 0.02 0.05
Interest 0.08 0.07 0.11 0.10 0.09 0.12 0.16 0.15 0.15 0.12 0.10 0.13 0.06
Depreciation 0.15 0.17 0.20 0.22 0.36 0.21 0.21 0.17 0.21 0.17 0.19 0.17 0.21
Profit before tax 2.78 1.18 0.86 0.56 2.02 0.50 0.06 -0.16 0.65 0.89 1.75 0.15 1.41
Tax % 29.50% 27.12% 22.09% 28.57% 28.71% 28.00% 33.33% -31.25% 29.23% 24.72% 25.14% 66.67% 21.28%
1.96 0.86 0.67 0.40 1.43 0.37 0.03 -0.11 0.45 0.66 1.31 0.06 1.11
EPS in Rs 5.45 2.39 1.86 1.11 3.97 1.03 0.08 -0.31 1.25 1.83 3.64 0.16 2.96
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
6.89 7.44 6.94 6.80 7.28 8.77 7.56 9.23 20.26 22.04 16.68 21.64
5.86 6.37 6.39 5.88 6.50 7.57 6.62 7.45 14.81 16.16 14.34 16.40
Operating Profit 1.03 1.07 0.55 0.92 0.78 1.20 0.94 1.78 5.45 5.88 2.34 5.24
OPM % 14.95% 14.38% 7.93% 13.53% 10.71% 13.68% 12.43% 19.28% 26.90% 26.68% 14.03% 24.21%
0.03 0.02 0.05 0.01 0.17 0.04 0.05 0.07 0.10 0.14 0.12 0.12
Interest 0.42 0.37 0.40 0.32 0.32 0.38 0.35 0.29 0.30 0.45 0.61 0.41
Depreciation 0.76 0.77 0.65 0.42 0.38 0.51 0.51 0.50 0.63 0.95 0.81 0.74
Profit before tax -0.12 -0.05 -0.45 0.19 0.25 0.35 0.13 1.06 4.62 4.62 1.04 4.21
Tax % -58.33% 60.00% -26.67% 31.58% 44.00% 31.43% 61.54% 26.42% 29.44% 27.49% 27.88% 25.42%
-0.06 -0.09 -0.32 0.13 0.14 0.24 0.05 0.78 3.26 3.36 0.75 3.14
EPS in Rs -0.17 -0.25 -0.89 0.36 0.39 0.67 0.14 2.17 9.06 9.33 2.08 8.37
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 11%
5 Years: 23%
3 Years: 2%
TTM: 30%
Compounded Profit Growth
10 Years: 43%
5 Years: 129%
3 Years: -1%
TTM: 319%
Stock Price CAGR
10 Years: 24%
5 Years: 74%
3 Years: -14%
1 Year: 74%
Return on Equity
10 Years: 14%
5 Years: 21%
3 Years: 18%
Last Year: 20%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 3.60 3.60 3.60 3.60 3.60 3.60 3.60 3.60 3.60 3.60 3.60 3.75
Reserves 1.77 1.68 1.36 1.60 1.74 1.98 2.03 2.81 6.07 9.43 10.18 14.36
2.78 1.97 2.71 2.93 3.91 3.33 3.20 3.05 2.19 4.30 5.08 2.68
0.95 1.35 1.16 1.33 1.35 2.08 2.15 2.72 4.68 4.42 4.19 4.92
Total Liabilities 9.10 8.60 8.83 9.46 10.60 10.99 10.98 12.18 16.54 21.75 23.05 25.71
3.13 2.55 2.02 1.88 2.40 2.47 2.69 2.56 3.12 4.24 3.87 3.81
CWIP 0.00 0.00 0.77 0.99 1.25 1.81 1.64 1.65 1.66 0.93 0.93 0.93
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
5.97 6.05 6.04 6.59 6.95 6.71 6.65 7.97 11.76 16.58 18.25 20.97
Total Assets 9.10 8.60 8.83 9.46 10.60 10.99 10.98 12.18 16.54 21.75 23.05 25.71

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0.47 1.35 0.42 1.13 0.31 2.25 1.09 1.76 1.69 -0.04 -0.01 2.92
-0.49 -0.18 -0.86 -0.52 -1.01 -1.00 -0.53 -1.19 -1.41 -1.67 -0.04 -0.78
0.20 -1.14 0.22 -0.50 0.36 -1.17 -0.31 -0.45 -1.10 1.75 0.19 -1.61
Net Cash Flow 0.18 0.03 -0.22 0.10 -0.34 0.08 0.25 0.12 -0.82 0.04 0.14 0.54
Free Cash Flow -0.02 1.15 -0.46 0.63 -0.72 1.13 0.53 1.42 0.49 -1.38 -0.73 1.69
CFO/OP 54% 126% 98% 123% 45% 192% 135% 106% 48% 19% 47% 73%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 70.99 88.31 113.08 143.32 152.92 134.01 145.81 127.73 84.85 77.17 145.08 179.46
Inventory Days 670.58 359.32 243.33 301.93 276.44 216.62 272.02 194.20 157.41 285.83 463.17 275.46
Days Payable 29.71 32.67 18.86 49.65 37.10 54.15 48.57 17.55 32.22 12.45 57.32 60.45
Cash Conversion Cycle 711.86 414.96 337.55 395.60 392.26 296.48 369.25 304.38 210.04 350.55 550.93 394.47
Working Capital Days 107.01 116.27 110.97 107.35 100.27 42.87 37.66 23.33 63.06 101.68 157.77 180.14
ROCE % 3.56% 4.16% -0.80% 6.46% 5.06% 7.93% 5.30% 14.43% 46.15% 34.74% 9.12% 23.30%

Insights

In beta
Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Mar 2027 (P)
Research and Development (R&D) Expenditure
INR ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Debtors Turnover Ratio
Ratio ・Standalone data
Number of Permanent Employees
Count
Cumulative Pacemaker Implants
Units ・Standalone data
Planned Capex for Capacity Upgrade/Automation
INR Lakhs ・Standalone data
R&D Expenditure (Percentage of Turnover)
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
24.25% 24.25% 24.25% 24.25% 24.25% 24.25% 24.25% 24.25% 24.25% 24.25% 25.80% 31.70%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.14% 0.14% 0.00%
75.75% 75.76% 75.76% 75.76% 75.76% 75.75% 75.76% 75.75% 75.76% 75.61% 74.06% 68.30%
No. of Shareholders 5,8035,8966,2076,5806,6896,9927,0486,9816,9726,6656,5296,567

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports